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Background: Erectile dysfunction represents an important health problem and the instrument most frequently
used for the evaluation of its evaluation is the International Index of Erectile Function (IIEF-5).
Aim: Due to lack of adaptation and validation for Spanish-speaking populations, this study aimed to adapt and
validate the Colombian version of International Index of Erectile Function (IIEF-5).
Methods: Two independent samples were evaluated. One used to validate the scale and the other to calculate
cut-off point of this version, with 2,021 men from the general population and outpatients from a clinic. The age
range was 18 to 75 years old (M = 37.80; SD = 14.06). The second sample included 74 men, 64.9% did not
meet DSM-5 criteria for erectile dysfunction, and 35.1% meet DSM-5 criteria to ED. Age range was 19 to
73 years old (M = 40.38; SD = 13.22).
Outcomes: All participants answered the Spanish versions of the International Index of Erectile Function-5
(IIEF-5) and the Massachusetts General Health-Sexual Functioning Questionnaire.
Results: The Colombian version of IIEF-5 showed adequate psychometric properties, confirmed the one-
dimension factorization of the scale, and showed adequate evidence of reliability and validity. Significant differen-
ces were observed in the IIEF-5 total score between the non-clinical and clinical groups who meet DSM-5 criteria
for erectile dysfunction, with a large effect size. Also, the cut-off the Colombian version was set to 16, with an
area under the curve of 94.9%.
Clinical Implications: The Colombian version of the IIEF-5 is a useful evaluation instrument that provides to
determine the presence of erectile dysfunction compatible with DSM-5 criteria.
Strengths & Limitations: The inventory reports adequate psychometric properties, a confirmed one-dimen-
sional structure, evidence of reliability and validity, and the first cut-off point for Hispanic populations. A more
in-depth evaluation of the diagnosis of ED and thus replication in other Spanish-speaking countries and sexual
minorities is recommended.
Conclusion: The Spanish version of the IIEF-5 is a useful evaluation tool for identifying erectile dysfunction, fol-
lowing DSM-5 criteria. Vallejo-Medina P, Saffon JP, Alvarez-Muelas A, Colombian Clinical Validation of
the International Index of Erectile Function (IIEF-5). Sex Med 2021;XX:XXXXXX.
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Erectile Dysfunction (ED) is defined as the persistent inability
to attain and maintain an erection sufficient to permit satisfac-
tory sexual performance.1 It represents an important health prob-
lem, affecting psychological well-being and quality of life, as well
as the couple relationship.2,3 ED is a common disorder, whose
prevalence may vary from country to country.4 Its global preva-
lence is estimated at 3-76.5%.5 Many factors are involved in its1
2 Vallejo-Medina et aletiology, including vascular, hormonal, neurological, psychologi-
cal, and lifestyle causes.6 Furthermore, ED is associated with
numerous physiological diseases7 and the presence of psychologi-
cal disorder symptoms.8 For instance, erectile dysfunction has
been identified as a risk factor and as a comorbid symptom in
depression.7 On the other hand, several anxiety disorders have
been associated with ED,7 such as social phobia9,10 or general-
ized anxiety,11 and positive relationships with age and low quality
of life have also been described.12,13
The International Index of Erectile Function (IIEF)14 is
widely used for the evaluation of men's sexual issues15,16 and has
been translated into more than 32 languages,17 which makes it
the instrument most frequently reported by male patients as part
of the evaluation of their sexual function.18 The index uses five
domains to evaluate erectile function (6 items), orgasmic func-
tion (2 items), sexual desire (2 items), intercourse satisfaction (3
items), and overall satisfaction (2 items). A short version com-
posed of five items the IIEF-5, was developed to allow for the
evaluation of ED specifically, according to the criteria established
by the National Institutes of Health.1 In a systematic review by
Neijenhuijs et al.,17 the authors conclude that the IIEF-5
presents adequate evidence of criterion validity, moderate evi-
dence of structural and construct validity, and adequate evidence
of test-retest reliability. Nevertheless, despite these pieces of evi-
dence, the inventory includes items related to the erectile func-
tion domain and one item related to sexual satisfaction;
therefore, the unidimensionality of the scale should be assessed
to adequately determine its internal consistency.
The IIEF-5, also known as the Sexual Health Inventory for
Men, has shown good discriminant validity between patients
with and without ED, and it can identify different ED severity
levels.19,20 Therefore, this index is a primary criterion in clinical
trials around the world,21 and it is the most widely used tool for
the diagnosis of erectile dysfunction.18,20 More research on the
IIEF-5 cut-off point is considered necessary because different
cut-off points have been reported in different studies. In the orig-
inal version, Rosen et al.19 recommended a cut-off point of 21
points; however, the authors also indicated the need to determine
this cut-off point in other contexts. Thus, the Chinese version
scored 16 points,22 the Malay,23 and Korean24 versions scored
17, and the Portuguese25 version scored 18. The Dutch version
fails to indicate a specific cut-off point, but the authors suggest
that a value of 21 would lead to the wrong conclusions.26 Neijen-
huijs et al.17 indicate that the value of 21 is inaccurate due to the
significant imbalance between comparison groups, which would
skew the CART algorithm and the use of trained samples. In
view of the widespread use of the scale and its discrimination
capacity, we would like to highlight the lack of adaptation and
validation for Spanish-speaking populations. For this purpose,
the present study aimed to adapt and validate the IIEF-5 for the
Colombian population. Thus, we evaluated factor structure, dif-
ferent item psychometric properties, criterion validity, and dis-
criminant validity using clinical samples, and criteria were basedon the DSM-5.27 A specific and sensitive cut-off point to be
used for this Spanish language version was also determined.
Therefore, the research question is, will the IIEF-5 be an instru-
ment with evidence of reliability and validity in the Colombian
population?MATERIALS AND METHODS
Participants
The study evaluated two independent samples. The first sam-
ple was used to validate the scale. This sample consisted of 2,021
men from the general population and a group of outpatients
from a Colombian sexology clinic (hidden for review). The
“non-clinical” group (n = 936) reported no sexual dysfunction
problems. Whereas the “clinical” group (n = 1085) reported erec-
tile dysfunction issues. Participant age range was 18 to 75 years
old (M = 37.88; SD = 14.06). A total of 86.47% of the partici-
pants reported being exclusively heterosexual, 9.35% exclusively
homosexual, 2.72% asexual, and 3.46% indicated different levels
of bisexuality. All participants were Colombian; 38.30% lived in
Bogota, 9.3% in Medellín, 5.74% in Cali, 3.71% in Barran-
quilla, and 42.95% lived in other Colombian cities. Inclusion
criteria for this sample were being 18 years of age or older, living
in Colombia, and being literate, Exclusion criteria were not hav-
ing signed an informed consent form.
A second sample was used to validate the Spanish language
IIEF-5 cut-off point. This sample consisted of 74 men between
19 and 73 years of age (M = 40.38; SD = 13.22). The “non-ED”
group included volunteers not meeting DSM-525 diagnostic cri-
teria for ED; they represented 64.9% (n = 48) of the second sam-
ple. The remaining 35.1% (n = 26) of participants represented
the “ED” group, that is, people who met DSM-525 diagnostic
criteria for ED. ROC curve power calculation suggested a power
analysis in our case (ED n = 26; Controls n = 46; auc = 0.949;
sig.level = 0.05) of 1. Inclusion/exclusion criteria were the same
as those in the first sample. Table 1 presents additional informa-
tion about first and second samples.Instruments
International Index of Erectile Function-5 (IIEF-5)19. This
self-reporting instrument consists of five items that evaluate the
presence or absence of ED. Four of its items focus on erectile
function and one on sexual intercourse satisfaction. Response
options are given on a Likert-type scale with possible scores
between 1 and 5. Low values indicate the presence of ED symp-
toms.
Massachusetts General Hospital-Sexual Functioning Ques-
tionnaire (MGH-SFQ)28,29. The present study used the Colom-
bia-validated version for men, composed of five items. These
items evaluate sexual desire, sexual arousal, orgasm, erection, and
general satisfaction. The questionnaire uses a five-point Likert-
type scale (0 to 4) where scores under 2 indicate possible sexualSex Med 2022;10:100461
Table 1. Demographic information, first sample and second sample








(n = 82) Contrast








t = 3.35; P < .01
Sexual
orientation
x2 = 91.94; P < .001 x2 = 2.51; P = .29
Asexual 3.70% 1.60% 0% 0%
Heterosexual 89.5% 78.50% 76.90% 97.90%
Bisexual 2.00% 5.00% 3.80% 2.10%
Homosexual 12.70% 5.50% 0% 13.40%
Couple
relationship
x2 = 83.6; P < .001 x2 = 0.86; P = .35
Sí 79.10% 60.50% 73.10% 87.50%
No 20.90% 39.50% 19.20% 12.50%
Marital Status x2 = 248.05; P < .001 x2 = 5.70; P = .22
Married 40% 17.40% 34.60% 29.20%
Single 26.70% 60.60% 15.40% 40.40%
Separated 9.60% 6.30% 11.50% 4.20%
Widowed 1.20% 0.30% 3.80% 2.10%
Common-law
marriage
21.50% 14.4.% 34.60% 22.90%
Medications x2 = 1.06; P = .03 x2 = 7.33; P < .01
Does use 8.76% 7.27% 4.90% 72.90%
Does not use 91.24% 92.73% 95.10% 27.10%
Disease x2 = 606.05; P < .001 x2 = 0.46;
P = .50
Yes 47,9% 97,8% 61.50% 29.20%
No 52,1% 2,2% 38.50% 70.80%
ED = erectile dysfunction.
Disease includes: apoplexy, high/low blood pleasure, thyroid issues, heart problems, cerebral infarction, urological problems, psychiatric diagnosis, anxiety,
alcohol abuse, drug abuse, diabetes, cancer, neurological issues, blood-related issues, STIs.
International Index of Erectile Function-Spanish 3problems. A Cronbach's alpha of .91 was observed in the present
study.Procedure
The study procedure began by considering the two Spanish lan-
guage versions of the IIEF-5 available at https://www.pfizerpcoa.
com/, the US Spanish and Spain Spanish versions. None of these
two versions was deemed adequate for the Colombian context.
Therefore, we decided to translate and adapt a new version specifi-
cally for the South American country of Colombia. Two indepen-
dent and certified translations were carried out by two independent
translators. These translations were discussed by a group including
experts in psychometrics and sexology and the translators them-
selves. After the discussion, a new version was created using contri-
butions from both translators. This new version was back-
translated into English and analyzed for content differences. The
process was conducted per international guidelines.30−32 The final
version will be available at https://www.pfizerpcoa.com/ and is
included in the Supplementary Materials section in this paper.
The study used two types of samples that collected between
June 2018 and June 2019. Data from the first sample was col-
lected using a web-based survey that was uploaded toSex Med 2022;10:100461SurveyMonkey and disseminated via social media (Facebook and
Twitter) and distributed to contacts in an updated patient direc-
tory provided by Boston Medical Group clinic, with which an
agreement was signed for the purposes of the present study. The
second sample was obtained by administering a pencil and paper
instrument to people who sought attention in the clinic due to
ED issues for the first time. Subjects without ED were adminis-
tered the instrument in libraries, universities, study halls, and
training rooms. Thus, all sampling was incidental and non-prob-
abilistic. Individual evaluations lasted approximately 10 minutes.Ethical Statement
This paper derives from a research project revised (Number:
2015-009 55270152) and approved by an ethical committee of
Fundacion Universitaria Konrad Lorenz. All subjects signed an
informed consent agreement, and confidentiality was maintained
throughout the study. Participation was voluntary and anonymous.Data Analysis
The items failed to present multivariate normal distribution
(Mardia Skewness = 781 and Mardia Kurtosis = 31). Therefore,
a robust statistic was used for the Structural Equation Model
4 Vallejo-Medina et al(SEM), as well as a robust estimation method (MLM) and, when
possible, robust indicators of fit (such as robust comparative fit
index (RCFI) and robust Tucker-Lewis index (RTLI). As usual,
values above .95 for the RCFI and RTLI and below .080 for
RMSEA were considered as good model fit indicators.33 Our rec-
ommendation is to use RMSEA with caution due to the low df
associated to our model that may biased this fit index.34 A poly-
choric matrix was used for obtaining results depending on a cor-
relation matrix. Therefore, all reported alphas were ordinal.
Confidence intervals for the ROC curves were obtained using
1000 bootstrapping samples.
Results were calculated using R software (Version 3.6.0)35
and the RStudio interface (Version 1.1.463).36 The psychomet-
rics packages used were: psych (R package, Version 1.7.8),37 psy-
chometric (R package, Version 2.2),38 wash, psycho (R package,
Version 0.5.0),39 semPlot (R package, Version 1.1.2),40 MVN
(R package, Version 5.8),41 and pROC (R package, Version
1.15.3).42 The ggplot2 tool was also used (R package, Version
3.1.1).43 The syntax of the analyses and data can be consulted in
the Github repository https://github.com/pableres/IIEFbrief.RESULTS
The IIEF-5 is usually presented as a one-factor scale. How-
ever, evidence for this structure is scarce, and only one study44
has tested it. In the present study, we conducted a different anal-
ysis to determine the number of IIEF-5 factors, and the highestFigure 1. Path diagram for the observed dimensiconsensus was associated with the one-dimensional structure, as
suggested by the methods of optimal coordinates, acceleration
factor, parallel analysis, kaiser, Vellicer MAP, and VSS complex-
ity 1. Among these, we would like to highlight parallel analysis
and MAP -probably the most reliable methods-. On the other
hand, Bayesian information criterion (BIC), sample size-adjusted
BIC, and VSS complexity 2 suggested a two-factor structure.
Consequently, we used confirmatory factor analysis to determine
the dimensional structure. Figure 1 shows the fit index and stan-
dardized loadings of the proposed model.
Once the scale dimensionality was settled, we evaluated sev-
eral item psychometric properties. As shown in Table 2, the
assessed psychometric properties were adequate.
Once the one-dimensionality of the scale was reliably con-
firmed, we tested for discriminant validity. A densitogram was cre-
ated to compare the group of volunteers who answered the survey
on the internet and were not attending a medical center due to
sexual dysfunction problems (non-clinical) with the group includ-
ing other volunteers and outpatients attending a medical center
who were at different stages (initial assessment to follow-up) of
ED treatment (Figure 2 A). Statistically significant differences with
considerable effect size differences were observed. Furthermore,
the correlation between IIEF-5 and MGHSFQ was r = .55 **.
Finally, we compared an independent clinical sample of indi-
viduals meeting DSM-527 criteria for ED who were visiting a
sexual dysfunction clinic for the first time with a sample of vol-
unteers not meeting DSM-527 criteria for ED. Both groups wereonality of IIEF-5. All loadings are standardized.
Sex Med 2022;10:100461
Table 2. Selected psychometric properties of IIEF-5
M(SD) min-max skewness kurtosis r.drop ord a-item ordinal a
IIEF_1 3.06(1.21) 1-5 -0.15 -0.85 .72 .90 .91
IIEF_2 3.76(1.23) 1-5 -0.67 -0.66 .79 .88
IIEF_3 3.56(1.29) 1-5 -0.47 -0.94 .81 .88
IIEF_4 3.74(1.28) 1-5 -0.59 -0.87 .83 .87
IIEF_5 3.42(1.19) 1-5 -0.31 -0.88 .69 .90
M(SD) = Mean (Standard Deviation); r.drop = item-total corrected correlation.
Pertinent analyses were performed with the polychoric matrix; therefore, all reported alphas are ordinal.
International Index of Erectile Function-Spanish 5combined in order to explore a cut-off point for the Colombian
Spanish version of the IIEF-5. As shown in Figure 2 B, the
results showed that the cut-off point with the highest balance
between sensitivity and specificity was 15.5. The area under the
curve (AUC) for this value was 94.9%. Subjects with scores of
16 or higher should not be considered as dysfunctional.DISCUSSION
Evidence of scale validity and reliability is essential for their
successful use in research and clinical practice. In this regard, an
adequate cultural interpretation of the IIEF-5 requires the valida-
tion of both cultural content and cut-off parameters.18 The pres-
ent validation of the IIEF-5 validation for Spanish language
reports on its adequate psychometric properties, a confirmed
one-dimensional structure, evidence of reliability and validity,
and a specific cut-off point for Colombia: the first for Hispanic
populations.
Given the limited number of studies exploring IIEF-5 fac-
tors,17 we evaluated the content validity of the instrument. The
index was originally presented as a one-dimensional scale,19 and
subsequently, Lin et al.44 successfully replicated it under that
consideration. In the present study, standardized weight scores
ranged from .70 to .84. Analyses showed adequate the psycho-
metric properties of the inventory, and corrected item-totalFigure 2. (A) Densitogram for both groups using
Sex Med 2022;10:100461correlation values were adequate. Previous studies have also
reported adequate psychometric properties.17 In the present
study, the value of ordinal alpha was .91. This value is very simi-
lar to those found in other studies, in which Cronbach's alpha
scores of .64.22, .8925, .9023, .9113, and .9426 have been
reported. Specifically, the value in this study was the second
highest in comparison with previous studies, which provides evi-
dence for the results found.
Secondly, it was exanimated the discriminant validity to evi-
dence differences between the clinical and non-clinical groups to
enable to perform the ROC curves. Significant differences were
observed in the IIEF-5 total score between the non-clinical and
clinical groups, with a large effect size. Thus, as indicated in the
original version by Rosen et al.19, the index obtained good evi-
dence of discriminant validity, differentiating the presence of
ED. Additionally, the IIEF-5 correlated positively and signifi-
cantly with the MGHSFQ. Lower scores on the MGHSFQ
would indicate possible problems in sexual functioning which is
associated with lower scores on the IIEF-5. In turn, lower scores
on the index may indicate the possible presence of erection diffi-
culties. This association would indicate optimal attributes con-
cerning its validity with respect to a criterion. Finally, we
established that a score lower than 16 indicates the possible pres-
ence of ED. This score differs from the originally presented value
of 21reported by Rosen et al.19, although the authors indicatedIIEF raw scores. (B) ROC curve for the IIEF-5.
6 Vallejo-Medina et althe need to determine cut-off points for other samples. In this
way, it could be considered this value of the cut-off point specific
for Colombian population. Moreover, none of the studies that
have tested this cut-off point have used the same value for other
countries, for instance, in China (16),22 in Malaysia (17),23 Por-
tugal (18),25 Korea (17),24 or the Netherlands.26 In Colombia,
we also used a lower category and considered the traditional mild
erectile dysfunction (scores between 17 and 21) as a non-clinical
category. Scores equal or higher to 16 seem to be adequate to
exclude ED problems in general. On the other hand, the 21 cut-
off point has been considered as inaccurate due to very unequal
group sizes, which biases the results of the CART algorithm, and
due to the use of a training sample for cross-validation.17 Never-
theless, methodologies other than COR curves are likely to help
close this debate.
Despite the inventory showed compatible with criteria DSM-
5,27 it is required a more in-depth evaluation of the diagnosis of
ED. The inventory allows the detection of the possible presence
of ED. Moreover, it should be noted that for the analysis of the
cut-off point in this study, the “non-ED” group included a larger
sample that “ED” group. It is recommended greater research on
the cut-off points to determine scores equal or higher to 16 seem
are adequate to exclude ED problems. Another limitation of this
study was that the sample was Colombian and mostly heterosex-
ual. For this reason, we are unsure if the instrument can be used
with other Spanish-speaking populations and sexual minorities
with guaranties, further research is needed on this issue.CONCLUSION
In conclusion, our findings support that the Spanish ver-
sion of the IIEF-5 is reliable and valid, with evidence for the
appropriateness of this version as an instrument for evaluat-
ing erectile dysfunction in the Colombian population. In
addition, this version provides the first Hispanic cut-off point
which can enable clinicians and psychotherapists to deter-
mine the presence of erectile dysfunction, compatible with
DSM-5 criteria. Therefore, the Colombian version is a tool
that can be used as a resource evaluation and guide the treat-
ment of erectile dysfunction. Finally, this validation provides
an opportunity to research and compare the evaluation and
treatment of erectile in different cultures.
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